A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combi...

por Wang, Chin-Chou, Chiu, Li-Chung, Tung, Pi-Hung, Kuo, Scott Chih-Hsi, Chu, Chia-Hsun, Huang, Allen Chung-Cheng, Wang, Chih-Liang, Chen, Chih-Hung, Yang, Cheng-Ta, Hsu, Ping-Chih
Publicado 2021

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study

por Hsu, Ping-Chih, Huang, Chun-Yao, Wang, Chin-Chou, Kuo, Scott Chih-Hsi, Chu, Chia-Hsun, Tung, Pi-Hung, Huang, Allen Chung-Cheng, Wang, Chih-Liang, Chiu, Li-Chung, Fang, Yueh-Fu, Yang, Cheng-Ta
Publicado 2020

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer

por Chu, Chia‐Hsun, Chiu, Tzu‐Hsuan, Wang, Chin‐Chou, Chang, Wen‐Chen, Huang, Allen Chung‐Cheng, Liu, Chien‐Ying, Wang, Chih‐Liang, Ko, Ho‐Wen, Chung, Fu‐Tsai, Hsu, Ping‐Chih, Guo, Yi‐Ke, Kuo, Chih‐Hsi S., Yang, Cheng‐Ta
Publicado 2020